ESALY - Eisai Co. Ltd. (ESALF) Management on Q1 2022 Results - Earnings Call Transcript
Eisai Co., Ltd. (ESALF) Q1 2022 Earnings Conference Call August 04, 2021 03:00 AM ET Company Participants Ryohei Yanagi - Executive Vice President & Chief Financial Officer Ivan Cheung - Senior Vice President & President of Neurology Business Group Terushige Iike - Senior Vice President & President, Oncology Business Group Teiji Kimura - Science & Neurology Business Group Teruyuki Masaka - In-charge, Business Planning Takashi Owa - Vice President, Chief Medicine Creation Officer, Oncology Business Group Conference Call Participants Motoya Kohtani - Nomura Securities Hidemaru Yamaguchi - Citigroup Securities Kazuaki Hashiguchi - Daiwa Securities Fumiyoshi Sakai - Credit Suisse Presentation Unidentified Company Representative It is now time. We would like to begin financial results presentation from the first quarter of fiscal 2021 by Eisai Co. Ltd. The presentation will be livestreamed and will also be distributed to participants via telephone line. Those who are participating via telephone line, please go
For further details see:
Eisai Co., Ltd. (ESALF) Management on Q1 2022 Results - Earnings Call Transcript